Colin Sanner
Payments from drug & device makers
Across 79 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$637
- Biogen$324
- Novartis$171
- Supernus Pharmaceuticals, Inc.$155
- AbbVie$140
- Amgen$113
- plus $533 from 18 others
What the payments were for
- Consulting fees$1507%
- Travel & lodging$42020%
- Food & beverage$1,50473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 4 | $637 |
| Biogen | 10 | $324 |
| Novartis | 12 | $171 |
| Supernus Pharmaceuticals, Inc. | 11 | $155 |
| AbbVie(2 entities) | 8 | $140 |
| Amgen | 6 | $113 |
| Lilly USA, LLC | 6 | $73 |
| UCB, Inc. | 2 | $66 |
| SK Life Science, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Dynasplint Systems Inc. | 1 | $35 |
| Lundbeck LLC | 2 | $34 |
| Portola Pharmaceuticals, LLC | 1 | $32 |
| EMD Serono, Inc. | 2 | $26 |
| Adamas Pharmaceuticals, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,074 in reported general payments places this provider in the 45th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amitriptyline Hcl | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other neurology in Waco
- Ann BassSan Antonio$12.3M
- Kandasami SenthilkumarBeaumont$7.6M
- Bharathy SundaramSherman$7.2M
- Bhupesh DiheniaLubbock$6.9M
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- Elizabeth PeckhamRound Rock$5.4M
- Susan IannacconeDallas$5.1M
- Benjamin GreenbergDallas$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.